https://www.selleckchem.com/pr....oducts/ph-797804.htm
4% of older adults with chronic polypharmacy), short-acting benzodiazepines (older adults 13.7%; middle-aged 16.1%), hypnotics (6.1%; 7.4%), and long-acting sulfonylureas (3.9%; 12.3%). The burden of chronic PIM appeared to be very high in our study, concerning almost half of middle-aged adults and two-thirds of older adults with chronic polypharmacy. Deprescribing interventions in polypharmacy should primarily target proton pump inhibitors and hypnotics.Carotenoids may strengthen the association of antioxidant vitamins A, C, and E wi
Like
Comment
Share
